优化给药:非小细胞肺癌精准医疗的下一步
本文综述了非小细胞肺癌(NSCLC)治疗中剂量优化的证据,聚焦小分子抑制剂、化疗药物和单克隆抗体。尽管存在研究非NSCLC或回顾性分析的局限,替代给药方案可能改善治疗结局、处方便利性或医疗系统经济负担,并为实施剂量优化提供建议。
要点
- NSCLC中「一刀切」剂量或基于次要参数给药常增加药代动力学变异且不改善结局。
- 治疗药物监测等药理学知识增长为优化给药提供价值。
- 替代给药方案可能利于结局、处方便利性或经济负担,但需进一步研究。
核心结论
- 在NSCLC治疗中,剂量优化是精准医疗常被忽视的部分,替代给药方案可能带来获益但需进一步研究。
研究设计与样本
- 本文为文献综述,聚焦已批准用于NSCLC的小分子抑制剂、化疗药物和单克隆抗体的优化给药方案证据。
主要发现
- 许多药物仍采用「一刀切」方案或基于常为系统暴露次要决定因素的参数给药,引入额外药代动力学变异且不改善结局。
- 药理学知识增长为治疗药物监测等优化给药策略提供了有价值信息。
临床怎么用
- 本文为实施剂量优化提供建议,并指出值得在NSCLC中进一步研究的策略。
局限性
- 部分研究在非NSCLC肿瘤疾病中进行,且许多分析为回顾性来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In oncology, and especially in the treatment of non-small-cell lung cancer (NSCLC), dose optimization is often a neglected part of precision medicine. Many drugs are still being administered in "one dose fits all" regimens or based on parameters that are often only minor determinants for systemic exposure. These dosing approaches often introduce additional pharmacokinetic variability and do not add to treatment outcomes. Fortunately, pharmacological knowledge is increasing, providing valuable information regarding the potential of, for example, therapeutic drug monitoring. This article focuses on the evidence for the most promising and easily implemented optimized dosing approaches for the small-molecule inhibitors, chemotherapeutic agents, and monoclonal antibodies as treatment options currently approved for NSCLC. Despite limitations such as investigations having been conducted in oncological diseases other than NSCLC or the retrospective origin of many analyses, an alternative dosing regimen could be beneficial for treatment outcomes, prescriber convenience, or financial burden on healthcare systems. This review of the literature provides recommendations on the implementation of dose optimization and advice regarding promising strategies that deserve further research in NSCLC.
引用
- Boosman RJ, Burgers JA, Smit EF, et al. Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer. Drugs. 2021. PMID: 34894338. doi:10.1007/s40265-021-01654-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。